Vice President - Technical

Mo Heidaran, PhD

Impact of COVID-19 on Manufacturing of Cell and Gene Therapy and Biotech Products, and Overall Clinical Trial Landscape
Friday, August 28, 2020
Novel coronavirus SARS-CoV-2, the causative agent for COVID-19, has disrupted the global clinical trial landscape in just a few short months. This virus is part of a larger family called Coronaviridae, which includes viruses ... read more
Major CMC Commercialization Gaps for Gene Therapy Products Manufactured for a Diverse Pediatric Subpopulation(s)
Tuesday, August 27, 2019
The development of cell and gene therapy products to address serious and life-threatening conditions that affect the pediatric population is growing exponentially. Although much is known about the Chemistry and Manufacturing ... read more